Dr. Kenneth M. Rice's lab at the University of Washington focuses on improving genetic risk prediction for diseases such as Alzheimer's through advanced statistical methodologies. By developing Polygenic Risk Scores (PRS) and collaborating with diverse research groups, the lab aims to create more accurate tools for personalized medicine that benefit a wider range of populations. The lab also emphasizes training and collaboration to enhance scientific understanding and application of genetic research in clinical contexts.

Dr. Sara Mostafavi's lab at the University of Washington focuses on using advanced computational models to understand how genetic variations influence gene expression and contribute to complex diseases like autism spectrum disorder and schizophrenia. By integrating diverse genomic data, the lab works to develop tools that can predict functional outcomes from personal genomes, helping to uncover the biological processes behind these conditions and potentially leading to personalized therapeutic strategies.

Dr. James P. Hughes leads a research lab focused on improving statistical methods for HIV/AIDS research. His work aims to enhance clinical trials and laboratory studies related to HIV, ultimately contributing to better prevention and treatment strategies. The lab's statistical innovations are also applicable to other communicable diseases, making it a significant contributor to public health efforts.

Ali Shojaie's research lab focuses on developing innovative statistical methods and machine learning techniques to create non-invasive biomarkers for early detection of Alzheimer's disease and related dementias. The lab aims to improve our understanding of how brain connectivity changes in these disorders, paving the way for better diagnostic tools and therapies. By leveraging advanced imaging data, the lab strives to provide new insights into the disease's initiation and progression to aid in timely intervention.